Envestnet Asset Management’s Harbor International Compounders ETF OSEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
60,442
+5,851
+11% +$177K ﹤0.01% 3215
2026
Q1
$1.58M Sell
54,591
-5,165
-9% -$156K ﹤0.01% 3168
2025
Q4
$1.81M Sell
59,756
-15,520
-21% -$470K ﹤0.01% 2904
2025
Q3
$2.23M Sell
75,276
-32,151
-30% -$939K ﹤0.01% 2811
2025
Q2
$3.14M Sell
107,427
-97,890
-48% -$2.72M ﹤0.01% 2515
2025
Q1
$5.45M Buy
205,317
+23,900
+13% +$642K ﹤0.01% 2065
2024
Q4
$4.69M Buy
181,417
+22,837
+14% +$624K ﹤0.01% 2140
2024
Q3
$4.59M Buy
158,580
+115,003
+264% +$3.21M ﹤0.01% 2152
2024
Q2
$1.21M Buy
+43,577
New +$1.19M ﹤0.01% 2911

Other funds holding OSEA

Envestnet Asset Management's OSEA Position: Q2 2026 in Review

Envestnet Asset Management increased its Harbor International Compounders ETF (OSEA) stake by 11% in Q2 2026, buying an estimated $177K and bringing the position to 60,442 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

Envestnet Asset Management first reported a position in OSEA in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.45M in Q1 2025. 65 funds tracked by Wall St. Rank hold OSEA as of Q2 2026.

  • Envestnet Asset Management held 60,442 shares of Harbor International Compounders ETF worth $1.85M as of Q2 2026.
  • Envestnet Asset Management bought 5,851 Harbor International Compounders ETF shares in Q2 2026, an estimated $177K.
  • Harbor International Compounders ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3215 holding.
  • Envestnet Asset Management first reported a position in Harbor International Compounders ETF in Q2 2024 and has held it in 9 quarters since.
  • Envestnet Asset Management's Harbor International Compounders ETF position peaked at $5.45M in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Harbor International Compounders ETF as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.